RBD directed IgA-serum-reactivities were higher in COVID-19 convalescents as compared to SARS-CoV-2 naïve subjects immediately after vaccination (p = 0.0158) and 6 months after vaccination (p < 0.0001, Fig. S1). The gene discussed is CD79A; the disease is COVID-19.